Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 65-73

  Oh, Yun K ^a   Bachar, Adi R ^a   Zacharias, David G ^a   Kim, Sung Gyun ^a   Wan, Junxiang ^b   Cobb, Laura J ^b   Lerman, Lilach O ^a   Cohen, Pinchas ^b   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ApoE deficient mice; Atherosclerosis; Endothelial dysfunction; Humanin

Indexed keywords

3 NITROTYROSINE; APOLIPOPROTEIN E; HNGF6A; HUMANIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; FEMALE; HYPERCHOLESTEROLEMIA; LONG TERM CARE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; TREATMENT OUTCOME;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DISEASE PROGRESSION; FEMALE; HYPERCHOLESTEROLEMIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PLAQUE, ATHEROSCLEROTIC;

EID: 80054969930     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.06.038     Document Type: Article

References (30)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-116.
2. Kinlay S., Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997, 80:11I-16I.
3. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
4. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
5. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
6. Galle J., Hansen-Hagge T., Wanner C., Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006, 185:219-226.
7. Littlewood T.D., Bennett M.R. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 2003, 14:469-475.
8. Hashimoto Y., Niikura T., Tajima H., et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and aβ. Proc Natl Acad Sci U S A 2001, 98:6336-6341.
9. Tajima H., Niikura T., Hashimoto Y., et al. Evidence for in vivo production of humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett 2002, 324:227-231.
10. Hashimoto Y., Niikura T., Ito Y., et al. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci 2001, 21:9235-9245.
11. Sonia S.J., William E.V.N. Humanin rescues human cerebrovascular smooth muscle cells from aβ-induced toxicity. J Neurochem 2003, 84:266-272.
12. Muzumdar R.H., Huffman D.M., Atzmon G., et al. Humanin: a novel central regulator of peripheral insulin action. PLoS One 2009, 4:e6334.
13. Hoang P.T., Park P., Cobb L.J., et al. The neurosurvival factor humanin inhibits β-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism 2010, 59:343-349.
14. Bachar A.R., Scheffer L., Schroeder A.S., et al. Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress. Cardiovasc Res 2010, 88:360-366.
15. Ikonen M., Liu B., Hashimoto Y., et al. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A 2003, 100:13042-13047.
16. Anderson T.J. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999, 34:631-638.
17. Kockx M.M., Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovascular Res 2000, 45:736-746.
18. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999, 99:348-353.
19. l during apoptosis. Proc Natl Acad Sci U S A 1997, 94:3668-3672.
20. Eskes R., Desagher S., Antonsson B., Martinou J-C. Bid induces the oligomerization and insertion of bax into the outer mitochondrial membrane. Mol Cell Biol 2000, 20:929-935.
21. Desagher S., Martinou J.-C. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000, 10:369-377.
22. Guo B., Zhai D., Cabezas E., et al. Humanin peptide suppresses apoptosis by interfering with bax activation. Nature 2003, 423:456-461.
23. Liu B., Lee H.-Y., Weinzimer S.A., et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid x receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 2000, 275:33607-33613.
24. Cohen P. Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 2006, 147:2109-2111.
25. Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000, 183:1-9.
26. Lue Y., Swerdloff R., Liu Q., et al. Opposing roles of insulin-like growth factor binding protein 3 and humanin in the regulation of testicular germ cell apoptosis. Endocrinology 2010, 151:350-357.
27. Muzumdar R.H., Huffman D.M., Calvert J.W., et al. Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice. Arterioscler Thromb Vasc Biol 2010, 30:1940-1948.
28. Upmacis R.K., Crabtree M.J., Deeb R.S., et al. Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: Contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol 2007, 293:H2878-H2887.
29. Beckmann J.S., Ye Y.Z., Anderson P.G., et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994, 375:81-88.
30. Adams M.R., Jessup W., Hailstones D., Celermajer D.S. l-Arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997, 95:662-668.